GHK-Cu is a tripeptide-copper(II) complex with the molecular formula CHNOCu and molecular weight of 403.93 Da (CAS: 49557-75-7)
All mechanistic claims for 5-Amino-1MQ in humans remain theoretical, and it is premature to draw firm conclusions about efficacy or safety in people
Compounding pharmacies make customized medicines for individual patients, and under section 503A of the Food, Drug, and Cosmetic Act, a pharmacy can compound from a bulk substance only if that substance has an official quality monograph, is a component of an FDA-approved drug, or has been formally added to an approved bulks list. BPC-157 qualifies on none of those counts, which is why the FDA placed it in Category 2 of its 503A bulk-substance review in September of 2023
The protein and mRNA levels of the first seven genes are elevated in patients with gastric cancer
V., & Swathi, M
For hair regrowth specifically, most research and clinical protocols use GHK-Cu